patient groups

The Make Blood Cancer Visible Campaign is supported by the following leading blood cancer patient support groups:


We’re the UK’s leading blood cancer research charity. We fund research to improve treatment and care for people living with all types of blood cancer – including leukaemia, lymphoma and myeloma – and provide anyone affected with information and support.


CLLSA is a patient led UK charity, our mission is to support and empower Chronic Lymphocytic Leukaemia (CLL) patients, their families and their carers through education and access to reliable, relevant and current information.


The UK's only patient led, registered charity with a sole focus on Chronic Myeloid Leukaemia.


Leukaemia Care is a national blood cancer support charity. We are dedicated to ensuring that anyone affected by blood cancer receives the right information, advice and support.


Lymphoma Action is the UK’s only charity dedicated to lymphoma, the UK’s fifth most common cancer. We’ve been providing in-depth, expert information and wide-ranging support for over 30 years, helping thousands of people affected by lymphoma. Our work drives improvements in the diagnosis, treatment, and aftercare of lymphoma.


Support, Information, Awareness and Campaigns for those affected by blood cancer Myelodysplastic Syndromes.


Myeloma UK is the only organisation in the UK dealing exclusively with myeloma, a blood cancer arising from plasma cells. We understand the impact that living with myeloma can have on patients, families and carers. Our ultimate goal is to find a cure and we need your help to do this.


A unique charity partnership of patients, doctors and carers fighting this rare blood cancer.


Leuka is the UK’s leading leukaemia research charity. We are at the forefront of research to determine the causes of the disease, to introduce safer, more effective treatments as fast as possible and ultimately, to find a cure. Thanks to research, leukaemia survival rates are improving and has more than quadrupled in the last 40 years in the UK.